Filter posts

Managing in a Cost-Constrained Environment

By Jill E. Sackman, D.V.M., Ph.D., Senior Consultant, and Matt Levy, J.D., Business Analyst, at …

Reviewing the drug class of 2011

The drug class of 2011 was larger than the past few graduating classes. We count …

Let's Get PDUFA V Approved, Fast

By Marc Boutin, JD, Executive Vice President and Chief Operating Officer, National Health Council At …

2012: A Critical Year for Biotechnology

In 2012, we must continue to look for ways to reduce risk; enhance reward; reduce …

The Ethics of Global Clinical Trials

By Dr. Russell Medford, Salutria Pharmaceuticals Recent reports have raised concerns about how clinical trials are …

CHI Offering Free Webinar on FDA Draft Guidances

The California Healthcare Institute will be hosting a free online discussion on Tuesday, October 25, 2011 that …

Medical Innovation at Risk

The National Venture Capital Association’s MedIC Coalition recently released a report showing U.S. venture capitalists …

Boosting Investment in Biotech

The President’s Council on Jobs and Competitiveness issued an interim report with suggestions to increase …

Is Animal Biotechnology Progressing?

By David Edwards, PhD Director, Animal Biotechnology, BIO One year ago, I was pleased to …

How to grow the economy and feed the world

By Barbara Wells, President and CEO, ArborGen Chair, BIO Food and Agriculture Section Governing Board …